1. Report Overview
1.1 Global Respiratory Inhalers Market Overview
1.2 Global Respiratory Inhalers Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Visiongain Reports
1.12 About Visiongain
2. Introduction to Respiratory Disorders and Therapies
2.1 An Introduction to Respiratory Disorders
2.1.1 Classification of Respiratory Disorders
2.1.2 Asthma
2.1.3 Chronic Obstructive Pulmonary Disease (COPD)
2.2 Major Drug Classes in the Treatment of Asthma and COPD
2.2.1 Bronchodilators
2.2.2 Phases of Clinical Trials
2.2.3 Regulation of Medical Devices
3. Respiratory Inhalers: Global Market Forecast 2020-2030
3.1 The Global Respiratory Inhalers Market in 2020
3.2 Leading Respiratory Inhaler Products
3.3 Leading Companies in the Respiratory Inhalers Market
3.4 Respiratory Inhalers: Trends and Developments
3.4.1 FDA Requires Replacement of CFC Inhalers with HFA Inhalers
3.4.2 The WISDOM Trial: Will Steroids Lose Their Role in COPD?
3.4.3 Telehealth: A Promising Market Trend
3.4.4 Lifecycle Management Strategies to Counter Patent Expiry
3.4.5 Advanced Inhaler Technologies to Counter Generic Erosion
4. Respiratory Inhalers Market by Product Type: Forecast 2020-2030
4.1 Metered Dose Inhalers: Market Forecast 2020-2030
4.2 Dry Powder Inhalers: Market Forecast 2020-2030
4.2.1 Single-Dose DPIs: Market Forecast 2020-2030
4.2.2 Multi-Dose DPIs: Market Forecast 2020-2030
4.3 Nebulizers: Market Forecast 2020-2030
4.3.1 Jet/Compressor Nebulizers: Market Forecast 2020-2030
4.3.2 Ultrasonic Nebulizers: Market Forecast 2020-2030
4.3.3 Vibrating-Mesh Nebulizers: Market Forecast 2020-2030
5. Respiratory Inhalers Market by Indication
5.1 Asthma: Market Forecast 2020-2030
5.2 COPD: Market Forecast 2020-2030
5.3 Other Respiratory Diseases: Market Forecast 2020-2030
6. Leading National Markets: Forecast 2020-2030
6.1 Regional Breakdown of the Global Respiratory Inhalers Market
6.2 World Respiratory Inhalers Market Forecast 2018-2030
6.2.1 How will Regional Market Shares Change to 2027?
6.3 The US Respiratory Inhalers Market 2020-2030
6.3.1 The US Respiratory Inhalers Market Forecast 2020-2030
6.3.2 US Respiratory Inhalers Market: Trends and Developments
6.4 EU5 Respiratory Inhalers Market 2020-2030
6.4.1 German Respiratory Inhalers Market Forecast 2020-2030
6.4.2 French Respiratory Inhalers Market Forecast 2020-2030
6.4.3 UK Respiratory Inhalers Market Forecast 2020-2030
6.4.4 Italian Respiratory Inhalers Market Forecast 2020-2030
6.4.5 Spanish Respiratory Inhalers Market Forecast 2020-2030
6.4.6 EU5 Respiratory Inhalers Market: Trends and Developments
6.5 Japanese Respiratory Inhalers Market 2018-2030
6.6 BRIC Respiratory Inhalers Market 2020-2030
6.6.1 Chinese Respiratory Inhalers Market Forecast 2020-2030
6.6.2 Indian Respiratory Inhalers Market Forecast 2020-2030
6.6.3 Brazilian Respiratory Inhalers Market Forecast 2020-2030
6.6.4 Russian Respiratory Inhalers Market Forecast 2020-2030
6.7 Mexican Respiratory Inhalers Market Forecast 2020-2030
6.8 Canadian Respiratory Inhalers Market Forecast 2020-2030
7. Leading Companies in the Respiratory Inhalers Market
7.1 GlaxoSmithKline (GSK)
7.1.1 GSK: Product Portfolio
7.1.2 GSK: Financial Overview
7.1.3 Recent Developments
7.2 AstraZeneca
7.2.1 AstraZeneca: Product Portfolio
7.2.2 AstraZeneca: Financial Overview
7.2.3 Recent Developments
7.2.4 AstraZeneca: Products in Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim: Product Portfolio
7.3.2 Boehringer Ingelheim: Financial Overview
7.3.3 Recent Developments
7.3.4 Boehringer Ingelheim: Respiratory Product Pipeline
7.4 Merck & Co. (Merck)
7.4.1 Merck: Product Portfolio
7.4.2 Merck: Financial Overview
7.4.3 Recent Developments
7.4.4 Merck: Products in Development
7.5 Teva
7.5.1 Teva: Product Portfolio
7.5.2 Teva: Financial Overview
7.5.3 Teva: Recent Developments
7.5.4 Teva: Products in Development
7.6 Novartis International AG
7.6.1 Novartis: Product Portfolio
7.6.2 Novartis: Financial Overview
7.6.3 Novartis: Recent Developments
7.6.4 Novartis: Products Under Development
7.7 Chiesi Farmaceutici S.p.A.
7.7.1 Chiesi: Product Portfolio
7.7.2 Chiesi: Financial Overview
7.7.3 Chiesi: Recent Developments
8. Research Interviews
8.1 Professor Peter J Barnes, Professor of Medicine
8.1.1 Professor Peter J Barnes FRS, FMedSci, Margaret Turner-Warwick Professor of Medicine
8.1.2 Unmet needs of Asthma & COPD Patients
8.1.3 Personalization of Respiratory Disease Treatments
8.1.4 Changing Trends in Prevalence & Incidence
8.1.5 Changes in Class of Inhalers
8.2 David Van Sickle, CEO of Propeller Health
8.2.1 Propeller Health
8.2.2 Unmet needs of Asthma & COPD Patients
8.2.3 Proven Outcomes & Expansion of Propeller Health
8.2.4 Features of Propeller Health Sensors
8.2.5 Major Changes in This Decade
9. Qualitative Analysis of Respiratory Inhalers Market
9.1 Market Dynamics
9.1.1 Drivers and Opportunities
9.1.2 Restraints and Challenges
9.2 Porter's Five Forces Analysis of the Respiratory Inhalers Market
9.2.1 Rivalry among Competitors [Medium]
9.2.2 Threat of New Entrants [Medium]
9.2.3 Power of Suppliers [Medium]
9.2.4 Power of Buyers [High]
9.2.5 Threat of Substitutes [Low]
10. Conclusions
10.1 Respiratory Inhalers: A Maturing Market
10.2 The Global Respiratory Inhalers Market, 2018 - 2030
10.3 Leading Respiratory Inhalers
10.4 Leading Respiratory Inhaler Companies
10.5 Leading Regional and National Markets
10.6 Global Respiratory Inhalers Market Forecast, 2020-2030
10.7 The Future of Respiratory Inhalers Market
Appendices
Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables:
Table 2.1 Classification of Respiratory Diseases
Table 2.2 Clinical Trial Phases
Table 3.1 Top 5 Respiratory Inhalers: Revenue ($m) and Market Shares (%), 2018
Table 4.1 World Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Product Type, 2018-2030
Table 4.2 World Metered Dose Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 4.3 World Dry Powder Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), by Product Type, 2018-2030
Table 4.4 Types of Marketed Breezhaler Devices
Table 4.5 Single-dose DPI Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 4.6 Multi-dose DPI Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 4.7 World Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Type, 2018-2030
Table 4.8 World Jet Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 4.9 World Ultrasonic Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 4.10 World Vibrating-Mesh Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 5.1 World Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Disease Indication, 2018-2030
Table 5.2 World Asthma Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 5.3 World COPD Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 5.4 World Respiratory Inhalers Market for Other Diseases, Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.1 World Respiratory Inhalers Market: Revenues ($m) and Market Shares (%) by Region, 2020
Table 6.2 World Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Region, 2018-2030
Table 6.3 Market Shares (%) of Leading Regional Respiratory Inhalers Markets, 2020, 2025 and 2030
Table 6.4 US Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.5 EU5 Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2018-2030
Table 6.6 German Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.7 French Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.8 UK Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.9 Italian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.10 Spanish Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.11 Japanese Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.12 BRIC Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.13 Chinese Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.14 Indian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.15 Brazilian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.16 Russian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.17 Mexican Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 6.18 Canadian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Table 7.1 GSK: Overview
Table 7.2 GSK: Respiratory Inhaler Products
Table 7.3 GSK: Major Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030
Table 7.4 GSK: Respiratory Therapies Pipeline
Table 7.5 AstraZeneca: Overview
Table 7.6 AstraZeneca: Respiratory Inhaler Products
Table 7.7 AstraZeneca: Major Respiratory Inhalers Revenue ($m), AGR (%) and CAGR (%), by Product Type, 2018-2030
Table 7.8 AstraZeneca: Respiratory Therapies Pipeline
Table 7.9 Boehringer Ingelheim: Overview
Table 7.10 Boehringer Ingelheim: Respiratory Inhaler Products
Table 7.11 Boehringer Ingelheim: Major Respiratory Inhalers Revenue ($m), AGR (%) and CAGR (%) by Product Type, 2018-2030
Table 7.12 Merck: Overview
Table 7.13 Merck: Respiratory Inhaler Products
Table 7.14 Merck: Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030
Table 7.15 Teva: Overview
Table 7.16 Teva: Respiratory Inhaler Products
Table 7.17 Teva: Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030
Table 7.18 Teva: Respiratory Product Pipeline
Table 7.19 Novartis: Overview
Table 7.20 Novartis: Respiratory Inhaler Products
Table 7.21 Novartis: Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030
Table 7.22 Novartis: Respiratory Product Pipeline
Table 7.23 Chiesi: Overview
Table 7.24 Chiesi: Respiratory Inhaler Products
Table 7.25 Chiesi: Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030
Table 9.1 Top 5 Respiratory Inhalers: Revenue ($m) and Market Shares (%), 2018
List of Figures
Figure 1.1 Ageing Population Estimates 2010 - 2050
Figure 1.2 Global Respiratory Inhalers: Market Segmentation
Figure 2.1 Summary of GINA Guidance for Asthma Treatment, 2019
Figure 2.2 Summary of GOLD Guidance for COPD Treatment 2019
Figure 3.1 World Respiratory Inhalers Market: Market Shares (%) for Major National Markets 2020
Figure 3.2 Top 5 Respiratory Inhalers: Market Shares (%), 2018
Figure 4.1 Respiratory Inhalers Market Forecast: Revenues ($m) by Product Type, 2018-2030
Figure 4.2 Metered Dose Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 4.3 World Dry Powder Inhalers Market Forecast: Revenues ($m) by Product Type, 2018-2030
Figure 4.4 Single-dose DPI Market Forecast: Revenues ($m) and AGR (%), 2020-2030
Figure 4.5 Multi-dose DPI Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 4.6 World Jet Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Figure 4.7 World Ultrasonic Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Figure 4.8 World Vibrating-Mesh Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030
Figure 5.1 World Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Disease Indication, 2018-2030
Figure 5.2 World Asthma Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 5.3 World COPD Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 5.4 World Respiratory Inhalers Market for Other Diseases, Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.1 Respiratory Inhalers Market: Revenues ($m) by Region, 2020
Figure 6.2 World Respiratory Inhalers Market: Market Shares (%) by Region, 2020
Figure 6.3 World Respiratory Inhalers Market Forecast: Revenues ($m) by Region, 2018-2030
Figure 6.4 World Respiratory Inhalers Market: Market Shares (%) by Region, 2020
Figure 6.5 World Respiratory Inhalers Market: Market Shares (%) by Region, 2025
Figure 6.6 World Respiratory Inhalers Market: Market Shares (%) by Region, 2030
Figure 6.7 US Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.8 EU5 Respiratory Inhalers Market Forecast: Revenues ($m) by National Market, 2018-2030
Figure 6.9 German Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.10 French Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.11 UK Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%), 2018-2030
Figure 6.12 Italian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.13 Spanish Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.14 Japanese Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.15 BRIC Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.16 Chinese Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.17 Indian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.18 Brazilian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.19 Russian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.20 Mexican Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 6.21 Canadian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030
Figure 7.1 GSK: Major Respiratory Inhalers Revenue ($m), 2018
Figure 7.2 GSK: Major Respiratory Inhalers Revenue Share (%) by Product, 2018
Figure 7.3 GSK: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030
Figure 7.4 AstraZeneca: Major Respiratory Inhalers Revenue ($m), 2018
Figure 7.5 AstraZeneca: Major Respiratory Inhalers Revenue Share (%), by Product, 2018
Figure 7.6 AstraZeneca: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030
Figure 7.7 Boehringer Ingelheim: Major Respiratory Inhalers Revenue ($m), 2018
Figure 7.8 Boehringer Ingelheim: Major Respiratory Inhalers Revenue Share (%), by Product, 2018
Figure 7.9 Boehringer Ingelheim: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030
Figure 7.10 Merck: Major Respiratory Inhalers Revenue ($m), 2018
Figure 7.11 Merck: Major Respiratory Inhalers Revenue Share (%) by Product, 2018
Figure 7.12 Merck: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030
Figure 7.13 Teva: Major Respiratory Inhalers Revenue ($m), 2018
Figure 7.14 Teva: Major Respiratory Inhalers Revenue Share (%) by Product, 2018
Figure 7.15 Teva: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030
Figure 7.16 Novartis: Major Respiratory Inhalers Revenue ($m), 2017
Figure 7.17 Novartis: Major Respiratory Inhalers Revenue Share (%), by Product, 2018
Figure 7.18 Novartis: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030
Figure 7.19 Chiesi: Foster Inhaler Revenue ($m) and AGR (%), 2018-2030
Figure 8.1 Porter's Five Forces Analysis of the Respiratory Inhalers Market, 2018-2030
Figure 9.1 Respiratory Inhalers Market Forecast: Revenues ($m) by Product Type, 2018-2030
